Trial NCT01199367

View at ClinicalTrials.gov 
Org. Study IDs: 2450-US-002

Last trial update was posted on 2014-04-07

MeSH Interventions

Lapatinib Letrozole

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer

Stopping Reasons

The results of the dose escalation phase did not identify a well-tolerated dose that would permit further study in Phase 2.

Limitations And Caveats

N/A

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID